Identiv (INVE) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
25 Dec, 2025Executive summary
Completed sale of physical security business and transitioned to a pure-play RFID/IoT solutions company, focusing on specialty RFID and BLE IoT solutions.
Launched and executing the Perform, Accelerate, Transform (PAT) strategic framework to drive operational excellence and growth.
Strengthened leadership with key hires, including a new Head of Commercial Organization and healthcare business development lead.
Strategic partnerships and expanded new product development pipeline, including with Novanta for medical device OEMs.
Financial highlights
Q4 2024 revenue was $6.7 million, down from $11.3 million in Q4 2023; FY 2024 revenue was $26.6 million, down from $43.4 million in FY 2023.
Q4 2024 GAAP and non-GAAP gross margin were -14.9% and -5.2%, respectively, both down from positive margins in Q4 2023.
Q4 2024 GAAP net loss from continuing operations was $4.3 million ($0.19/share); FY 2024 GAAP net loss was $25.9 million ($1.14/share).
Q4 2024 non-GAAP adjusted EBITDA was -$4.5 million; FY 2024 non-GAAP adjusted EBITDA was -$15.8 million.
Repurchased approximately 464,000 shares for $1.9 million in Q4 2024.
Outlook and guidance
Q1 2025 net revenue expected in the range of $4.8 million–$5.1 million, reflecting customer order timing and market conditions.
Targeting Q4 2025 non-GAAP gross margin of 26%-28%, with a long-term goal of 35%.
Expected net operating cash usage for the 12 months post-Q3 2024 remains $14 million–$16 million.
Growth from new projects expected to materialize more in 2026.
Will begin reporting PAT metrics quarterly starting Q1 2025.
Latest events from Identiv
- Margins improved and losses narrowed in Q4/FY 2025, with new BLE supply deal and strong 2026 outlook.INVE
Q4 202512 Mar 2026 - Q2 revenue and margins fell as a $145M asset sale and IoT pivot advance toward Q3 closure.INVE
Q2 20242 Feb 2026 - Asset sale drove $99.5M gain, $145.4M cash, but core revenue and margins declined.INVE
Q3 202415 Jan 2026 - Key proposals include board declassification, director elections, and auditor ratification.INVE
Proxy Filing1 Dec 2025 - Key votes include board declassification, director elections, officer exculpation, and auditor ratification.INVE
Proxy Filing1 Dec 2025 - Key votes include board declassification, director elections, and executive compensation approval.INVE
Proxy Filing1 Dec 2025 - Board refresh and declassification proposal signal governance reform and IoT strategy focus.INVE
Proxy Filing1 Dec 2025 - Executing growth strategy amid strong RFID demand, governance changes, and production shift.INVE
Proxy Filing1 Dec 2025 - Board declassification and new director appointment set for shareholder vote in 2025.INVE
Proxy Filing1 Dec 2025